Test bank Basic applied concepts of blood banking and transfusion practices 5th edition Newest Revised edition

Test Bank For Basic & Applied Concepts of Blood Banking an
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll




Practices 5th Edition – By Paula Howard
IIll IIll IIll IIll IIll IIll




| Verified Chapter's 1 - 16 | Complete
IIll IIll IIll IIll IIll IIll IIll

,Table of Contents IIll IIll




Part I: Quality and Safety Issues IIll IIll IIll IIll IIll




1. Quality Assurance and Regulation of the Blood Industry: Safety Issues in the Blood Bank……
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll




I I l l Part II: Foundations: Basic Sciences and Reagents
IIll IIll IIll IIll IIll IIll




2. Immunology: Basic Principles and Applications in the Blood Bank ………………………………… IIl IIll IIll IIl IIll IIl IIll IIl IIll




3. Blood Banking Reagents: Overview and Applications……………………………………………
Il IIl IIl Il Il




I I l l 4. Genetic
IIl Principles
IIl in
Il




Banking……………………………………………………………………………………….18
Il I I l l Pa

IIll Major Blood Groups IIll IIll




5. ABO and H Blood Group Systems and Secretor Status……………………………………………
IIll IIll IIl IIll IIll IIl IIll IIl IIll




I I l l 6. Rh
Il Blood
Il




System……………………………………………………………………………………………………
Il




7. Other Red Cell Blood Group Systems, Human Leukocyte Antigens, and Platelet Antigens………
IIll IIl IIll IIll IIl IIll IIl IIll IIll IIl IIll




I I l l Part IV: Essentials of Pretransfusion Testing
IIll IIll IIll IIll IIll




8. Antibody IIll IIll I I l l Detection IIll IIll I I l l and IIll IIll




I I l l Identification……………………………………………………………………………………34 I I l l 9. IIll IIll




IIll Testing………………………………………………………………………………………………………3

10. Blood Bank Automation for Transfusion Services………………………………………………… Il Il IIl IIl Il




I I l l Part V: Clinical Considerations in Immunohematology
IIll IIll IIll IIll IIl




11. AdverseComplicationsofTransfusions……………………………………………………………… Il Il Il




12. Hemolytic Disease of the Fetus and Newborn……………………………………………………… IIl IIl Il IIl IIl Il




I I l l Part VI: Blood Collecting and Testing
IIll IIll IIll IIll IIll




13. Donor Selection and Phlebotomy……………………………………………………………………
Il Il Il Il




I I l l 14. Testing
Il of
Il




Blood…………………………………………………………………………………………………….
Il




IIl Component Preparation and Transfusion Therapy IIll IIl IIl IIll

,Chapter 01: Quality Assurance and Regulation of the Blood Industry and Safety Issues in the B
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



I Howard: Basic & Applied Concepts of Blood Banking and Transfusion Practices, 5th Edition
I l l IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll




MULTIPLE CHOICE IIll




1. Biosafety levels determine: IIll IIll



a. on what floor certain infectious disease testing can be performed.
IIll II ll IIll IIll IIll IIll IIll IIll IIll



b. the degree of risk for certain areas of a health care facility to
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll I I ll IIll



exposure to
IIll infectious diseases. IIll I I l l IIll



c. the amount of ventilation required in a transfusion service.
IIll IIll IIll IIll II ll IIll IIll IIll



d. how many biohazardous waste containers a laboratory must have.
IIll IIll IIll IIll IIll I I ll IIll II ll




ANS: B IIll



OSHA defines biosafety levels based on potential exposure to infectious material.
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll




DIF: Level 1 IIll




2. A laboratory technologist decided she would like to bring her lab coat home for laundering becau
IIll IIll I I ll IIll IIll I I ll IIll IIll I I ll II ll IIll IIll I I ll IIll IIll



when
IIll



it was returned by the laboratory’s laundry service. Is this practice acceptable?
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



a. Yes, if she uses 10% bleach II ll IIll IIll IIll IIll



b. Yes, if she clears it with her supervisor II ll IIll IIll IIll IIll IIll IIll



c. Yes, as long as she removes the coat and does not wear it home II ll II ll IIll IIll IIll IIll IIll II ll IIll IIll IIll IIll II ll



d. No, because the laboratory is a biosafety level 2, and lab coats may
IIll IIll I I ll IIll IIll IIll IIll IIll IIll I I ll IIll IIll



not be removed IIll IIll I I l l




ANS: D IIll



Methods of transporting the lab coat and the risk of contamination do not permit health care worke
IIll IIll IIll I I ll IIll I I ll IIll IIll IIll IIll IIll I I ll I I ll II ll IIll IIll



for
I I ll cleaning. I I l l




DIF: Level 2 IIll




3. Personal protective equipment includes: IIll IIll II ll



a. safety glasses. IIll



b. splash barriers. IIll



c. masks.
d. All of the above IIll IIll IIll




ANS: D IIll



Safety glasses, splash barriers, and masks are types of personal protective devices.
IIll II ll IIll IIll I I ll IIll IIll IIll IIll IIll IIll




DIF: Level 1 IIll




4. At what point in the employment process should safety training take place?
IIll IIll IIll IIll IIll I I ll IIll IIll IIll IIll IIll



a. During orientation and training IIll IIll IIll



b. Following lab training when employees are more familiar with I I ll IIll IIll IIll IIll I I ll IIll IIll



their responsibilities
IIll I I l l



c. Following the employees’ first evaluation IIll IIll IIll II ll



d. Before independent work is permitted and annually thereafter
IIll I I ll IIll IIll IIll IIll IIll




ANS: D IIll



The Occupation Safety and Health Administration requires safety training before independent work
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIl



I thereafter.
I l l




DIF: Level 1 IIll




5. In safety training, employees must become familiar with all of the following except:
IIll IIll II ll IIll II ll I I ll IIll IIll IIll IIll IIll IIll



a. tasks that have an infectious risk. IIll IIll IIll IIll IIll

, 7. Which of the following is true regarding good manufacturing practices (GMPs)?
IIll IIll I I ll IIll IIll IIll IIll IIll IIll IIll



a. GMPs are legal requirements established by the Food and Drug Administration.
IIll I I ll IIll IIll IIll IIll IIll IIll IIll IIll



b. GMPs are optional guidelines written by the AABB. IIll IIll IIll IIll IIll IIll IIll



c. GMPs are required only by pharmaceutical companies. IIll IIll IIll IIll IIll IIll



d. GMPs are part of the quality control requirements for blood products. IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll




ANS: I I l l A
Good manufacturing practices are requirements established by the Food and Drug Administration.
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll




DIF: Level 1 IIll




8. Which of the following is an example of an unacceptable record-keeping procedure?
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



a. Using dittos in columns to save time IIll IIll IIll IIll II ll IIll



b. Recording the date and initials next to a correction IIll IIll IIll I I ll IIll IIll IIll IIll



c. Not deleting the original entry when making a correction
IIll IIll IIll IIll IIll IIll IIll IIll



d. Always using permanent ink on all records IIll IIll IIll IIll IIll IIll




ANS: I I l l A
All records must be clearly written. Dittos are unacceptable.
IIll II ll II ll IIll IIll IIll IIll IIll




DIF: Level 1 IIll




9. A technologist in training noticed that the person training her had not recorded the results of a tes
IIll I I ll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



carefully
IIll recorded the results she saw at a later time, using the technologist’s initials. Is this
I I l l IIll IIll IIll IIll IIll II ll IIll IIll II ll IIll IIll IIll IIll IIll



procedure?
IIll



a. Yes; all results must be recorded regardless of who did the test.
IIll IIll IIll IIll IIll IIll IIll IIll I I ll IIll IIll



b. No; she should have brought the error to the technologist’s attention.
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



c. Yes; because she used the other technologist’s initials.
IIll IIll IIll IIll IIll IIll IIll



d. Yes; as long as she records the result in pencil. IIll IIll IIll IIll IIll IIll IIll II ll IIll




ANS: B IIll



This is an example of poor record keeping; results must be recorded when the test is performed an
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



test.
IIll




DIF: Level 3 IIll




10. Unacceptable quality control results for the antiglobulin test performed in test tubes may be noticed IIll IIll IIll IIll IIll IIll IIll I Ill IIll IIll IIll IIll IIll IIll



a. preventive maintenance has not been performed on the cell washer. I I ll IIll IIll IIll IIll IIll IIll IIll IIll



b. the technologist performing the test was never trained.
IIll IIll IIll IIll IIll IIll IIll



c. the reagents used were improperly stored.
IIll IIll IIll IIll IIll



d. All of the above IIll IIll IIll




ANS: D IIll



Training, equipment maintenance, and reagent quality can affect quality control.
IIll IIll IIll IIll II ll IIll IIll II ll IIll




DIF: Level 2 IIll




11. All of the following are true regarding competency testing except:
IIll IIll I I ll IIll IIll IIll IIll IIll IIll



a. it must be performed following training.
IIll IIll IIll I I ll IIll



b. it must be performed on an annual basis.
IIll I I ll IIll IIll IIll IIll IIll



c. it is required only if the technologist has no experience.
IIll IIll IIll IIll IIll IIll I I ll IIll I I ll



d. retraining is required if there is a failure in competency testing. I I ll IIll I I ll IIll I I ll IIll I I ll I I ll IIll IIll




ANS: C IIll



All employees must have competency testing following training and annually thereafter. If there is
IIll IIll II ll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll II



testing,
IIll retraining is required. I I l l I I ll IIll




DIF: Level 2 IIll




12. Which of the following organizations are involved in the regulation of blood banks?
IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll IIll



a. The Joint Commission IIll IIll